EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Maat Pharma's enterprise value is €98.83 Mil.
Maat Pharma's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €2.23 Mil. Therefore, Maat Pharma's EV-to-Revenue for today is 44.36.
The historical rank and industry rank for Maat Pharma's EV-to-Revenue or its related term are showing as below:
XPAR:MAAT'
s EV-to-Revenue Range Over the Past 10 Years
Min: -18.6 Med: 27.52 Max: 56.58
Current: 44.36
During the past 6 years, the highest EV-to-Revenue of Maat Pharma was 56.58. The lowest was -18.60. And the median was 27.52.
XPAR:MAAT's EV-to-Revenue is ranked worse than 76.52% of 1039
companies
in the Biotechnology industry
Industry Median: 7.94
vs XPAR:MAAT: 44.36
As of today (2024-06-07), Maat Pharma's stock price is €7.86.
Maat Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.20. Therefore, Maat Pharma's PS Ratio for today is 39.90.
Maat Pharma EV-to-Revenue Historical Data
The historical data trend for Maat Pharma's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Maat Pharma's EV-to-Revenue
For the Biotechnology subindustry, Maat Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maat Pharma's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Maat Pharma's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Maat Pharma's EV-to-Revenue falls into.
Maat Pharma's current Enterprise Value is €98.83 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Maat Pharma's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €2.23 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maat Pharma's share price for today is €7.86.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €0.20.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maat Pharma EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Maat Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XPAR:MAAT has been successfully added to your 